Chemed Corporation

NYSE•CHE

CEO: Mr. Kevin J. McNamara

Sector: Healthcare

Industry: Medical - Care Facilities

Listing Date: 1973-05-03

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.

Contact Information

255 East Fifth Street, Suite 2600, Cincinnati, OH, 45202-4726, United States

513-762-6690

www.chemed.com

Market Cap

$5.43B

P/E (TTM)

20.3

15.2

Dividend Yield

0.6%

52W High

$623.61

52W Low

$376.20

52W Range

Rank16Top 3.7%

6.5

F-Score

Modified Piotroski Analysis

Based on 10-year fundamentals

Strong • 6.5 / 9 points

Scoring Range (0-9)

8-9: Excellent Value

6-7: Strong Fundamentals

4-5: Average Quality

0-3: Weak Performance

Data Period: 2016-2025

Financial Dashboard

Q4 2025 Data

Revenue

$639.34M+0.00%

4-Quarter Trend

EPS

$5.48+0.00%

4-Quarter Trend

FCF

$117.19M+0.00%

4-Quarter Trend

2025 Annual Earnings Highlights

Key Highlights

Consolidated Revenue Growth Consolidated service revenues reached $2.53B USD in 2025, marking a 4.1% increase over 2024 results.

VITAS Segment Revenue Up VITAS segment revenue increased 6.5% to $1.63B USD in 2025, driven by higher days-of-care volume.

Roto-Rooter Revenue Stable Roto-Rooter segment revenue remained flat at $900.0M USD for 2025, despite increased implicit price concessions.

Strong Liquidity Position Company maintains $404.5M USD in unused lines of credit available under the revolving credit facility.

Risk Factors

Medicare Payment Dependency Over 90% of VITAS revenue relies on Medicare/Medicaid; adverse regulatory changes could materially affect profitability.

Successful Cybersecurity Breach Experienced a successful PHI breach via third-party vendor in October 2025; ongoing threat mitigation is critical.

Profitability Impacted by Caps Increased Medicare Cap liability reduced VITAS net income by $18.7M, contributing to 12.2% net income decline.

Intense Market Competition Roto-Rooter faces intense competition; rising marketing costs challenge ability to maintain brand recognition.

Outlook

Debt Covenant Compliance Forecast Forecast compliance with all debt covenants through fiscal 2026, maintaining Leverage Ratio below 3.50 to 1.00.

VITAS Market Expansion Strategy VITAS growth strategy centers on successful identification and expansion into new and existing hospice markets.

Capital Allocation Review Management continually evaluates capital deployment including share repurchase, debt repayment, and increased dividends.

Monitoring New Accounting Rules Monitoring impact of ASU 2023-07 regarding segment expense disclosures, effective for fiscal periods beginning 2026.

Peer Comparison

Revenue (TTM)

UHS

$17.36B

+9.7%

DVA

$13.64B

+6.5%

HSIC

$13.18B

+4.0%

Gross Margin (Latest Quarter)

NHC

67.7%

+1.8pp

TFX

54.0%

-6.8pp

BRKR

47.8%

-3.6pp

Key Metrics

Symbol	Market Cap	P/E (TTM)	ROE (TTM)	Debt to Assets
UHS	$11.90B	8.0	21.0%	34.5%
ENSG	$11.77B	33.9	16.6%	76.1%
DVA	$10.01B	17.3	-160.6%	86.1%

Long-Term Trends

Last 4 Quarters

Revenue

Net Income

Operating Cash Flow

4Q Revenue CAGR

-0.4%

Flat Growth

4Q Net Income CAGR

2.3%

Profitability Slowly Improving

Cash Flow Stability

100%

Strong Cash Flow

Deep Research

Next earnings:Apr 21, 2026

EPS:-

Revenue:-

Financials

Earnings Calls

Reports

News

Income Statement

Balance Sheet

Cash Flow Statement

Ratios

% Chg.

Income Statement	LTM

No Data